Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 2 ... (lower cholesterol, lower blood pressure, improve blood sugar, defeat depression and chronicfatigue, etc.) while cranking up their metabolism and muscle growth. His New Body ... Farm, Food, Poultry, Aging, Alternative Medicine, Blood Pressure, Chronic Fatigue Syndrome, Metabolism, Therapy, Treatment, Virology, Weight Loss. This article was ...
2009 NOV 2 ... enrollment and dosing in a clinical study of its anti-CD200 antibody in patients with chronic lymphocytic leukemia. Early pharmacodynamic and biologic data suggest drug activity in ... can cause life-threatening thromboses, recurrent pain, kidney disease, disabling fatigue, impaired quality of life, severe anemia, pulmonary hypertension, shortness of breath ... primary focus on nephrology and organ transplant. Nephrology: Atypical Hemolytic Uremic Syndrome (aHUS) Enrollment of adult and adolescent patients for our lead nephrology program, ... for patients with PNH, researchers have been evaluating the potential of Soliris as a therapy for patients suffering with other rare and severe complement-mediated disorders. There ...
2009 NOV 16 ... Squibb (NYSE: BMY) announced 48-week data from an ongoing study (ETV-048) of chronic hepatitis B patients with decompensated cirrhosis, in which BARACLUDE demonstrated ... treated with BARACLUDE® (entecavir) in clinical trials included: headache (4%), fatigue (3%), diarrhea (1%), and dyspepsia (1%). The recommended dose of BARACLUDE ... Healt, Biochemical, Chemicals, Chemistry, Pediatrics, AIDS, Acquired Immunodeficiency Syndrome, Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Antiviral, Baraclude, ... is one of the first comparative studies to evaluate the safety and efficacy of antiviral therapy in this difficult-to-treat patient population," said Professor Hugo Cheinquer, ETV-048 ...
2009 SEP 14 ... knowledge about what might lie in store could be a big help." Keywords: ChronicFatigueSyndrome, Clinical Research, EBV, Epstein-Barr Virus, Herpes, Herpesvirus, ... Epstein-Barr Virus, Herpes, Herpesvirus, Multiple Sclerosis, Neuroimmunology, Neurology, Therapy, Treatment, Urology, Virology, Multiple Sclerosis Society. This article was ...
2009 NOV 2 ... Dr. Oz Show the topic was fatigue, including its most debilitating manifestation, ChronicFatigueSyndrome (CFS). Dr. Oz's guest Jacob Teitelbaum, MD, best-selling ... Fatigue Syndrome, Fibromyalgia, Fibromyalgia Syndrome, Hormones, Quality of Life, Therapy, Treatment, Virology, Dr. Teitelbaum. This article was prepared by Pain & ...
2009 NOV 2 ... earlier this year for the management of fibromyalgia. Fibromyalgia is a chronic condition characterized by widespread pain and decreased physical function, afflicting ... headache, constipation, hot flush, dizziness, insomnia, hyperhidrosis, palpitations, fatigue, tachycardia, and hypertension. The majority of adverse reactions reported were mild to ... risk of overdose. Development of a potentially life-threatening serotonin syndrome or neuroleptic malignant syndrome (NMS)-like reactions have been reported with SSRIs and ... or unusual changes in behavior, especially during the initial few months of drug therapy or at times of dose changes, either increases or decreases. Families and caregivers ...
Subject: Forest Laboratories, Inc. and Cypress Bioscience, Inc.
2009 NOV 16 ... of once-daily Viread® (tenofovir disoproxil fumarate) among adult patients with chronic hepatitis B virus (HBV) infection. These data will be presented at the annual meeting of ... Viread discontinued treatment due to adverse events (hepatocellular carcinoma, dizziness/fatigue/lack of concentration and septic shock). No patients experienced a confirmed 0.5 mg/dL ... or worsening of renal impairment including cases of acute renal failure and Fanconi syndrome has been reported with the use of Viread. It is recommended to assess creatinine ... Clinical practice guidelines recommending Viread as a first-line therapy for the treatment of chronic hepatitis B were issued earlier this year by both the ...
2009 NOV 16 ... Syndrome or Celiac Disease, individuals who have had bypass surgery, those undergoing chronictherapy with absorption-altering drugs, alcoholics and vegetarians/vegans. It is ... body's immune system. B12 deficiency is a major health concern that can lead to anemia, fatigue, weakness, loss of appetite, neurological changes, confusion and dementia. ...
2009 SEP 28 ... Germany, Marburg, Autoimmune Disease, Autoimmune Disorder, Biotechnology, Chickenpox, ChronicFatigueSyndrome, Dermatology, EBV, Epstein-Barr Virus, Herpes Zoster Virus, ... by ELISA before and at different time points after initiation of the respective therapy. In contrast to immunosuppressive therapy alone and in combination with adjuvant ...
2009 NOV 16 ... or peg-IFN-alfa-2b (PEGINTRON) and ribavirin (RBV), the currently approved therapies for chronic HCV infection. The Study C208 results being presented at AASLD represent the first SVR ... in patients in Study C208 were pruritis, nausea, rash, anemia, flu-like illness, fatigue and headache, and were similar overall between the patient groups receiving every 8 hour ... (Cell: 617-767-9533) Keywords: AIDS, Acquired Immunodeficiency Syndrome, Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Anemia, Biotechnology ... France. "These results also highlight the potential future role for response-guided therapy with the goal of improving treatment outcomes and potentially shortening the duration of ...
2009 NOV 9 ... response to infections and treatment should not be initiated in patients with active or chronic infections. There have been reports of serious, life-threatening infections in patients ... life-long, recurrent symptoms of rash, fever/chills, joint pain, eye redness/pain, and fatigue. Intermittent, disruptive exacerbations or flares can be triggered at any time by ... Syndromes (CAPS) with severe symptoms, including Familial Cold Auto-inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS), in adults and children aged 12 years and older. ... for review. Keywords: Regeneron Pharmaceuticals, Inc., Rilonacept, Drugs, Therapy, Treatment, Fatigue, Muckle-Wells Syndrome, Wells' Syndrome, Rheumatology, Immunology, ...
2009 SEP 21 ... "Chronicfatiguesyndrome (CFS) is a disease of unknown aetiology. A patient with CFS had ... Keywords: Norway, Bergen, Biotechnology, Chemotherapy, Chronic Fatigue Syndrome, Drug Therapy, Drugs, Medical Device, Methotrexate Sodium, Monoclonal Antibodies, Neurology, ...
2009 SEP 14 ... "Fibromyalgia syndrome (FMS) is a condition classified by widespread chronic pain and is associated with fatigue, morning stiffness and disordered sleep Milnacipran ... "In patients with FMS who are unable to tolerate first-line tricyclic antidepressant therapy, milnacipran may be a reasonable alternative or adjunct therapy. (Formulary. ...
2009 OCT 19 ... & Sons Inc., 111 River St., Hoboken, NJ 07030, USA. Keywords: Japan, Hongo, ChronicFatigueSyndrome, EBV, Epstein-Barr Virus, Hematology, Herpes, Herpesvirus, Large Cell ... lymphoma. This transition was associated with the progression of lung cancer and its therapy," wrote K. Taoka and colleagues, University of Tokyo. The researchers ...
2009 SEP 14 ... is also an excellent means of relieving many medical complaints including arthritis, chronicfatiguesyndrome, lymphoedema, varicose veins and deep vein thrombosis. It is also ... Japan, Marketing, Rugby, Singapore, Soccer, Sports, Technology, Tennis, Triathlon, Therapy, Treatment. This article was prepared by Biotech Business Week editors from ...
